RUO Home

Repositorio Institucional de la Universidad de Oviedo

View Item 
  •   RUO Home
  • Producción Bibliográfica de UniOvi: RECOPILA
  • Artículos
  • View Item
  •   RUO Home
  • Producción Bibliográfica de UniOvi: RECOPILA
  • Artículos
  • View Item
    • español
    • English
JavaScript is disabled for your browser. Some features of this site may not work without it.

Browse

All of RUOCommunities and CollectionsBy Issue DateAuthorsTitlesSubjectsxmlui.ArtifactBrowser.Navigation.browse_issnAuthor profilesThis CollectionBy Issue DateAuthorsTitlesSubjectsxmlui.ArtifactBrowser.Navigation.browse_issn

My Account

LoginRegister

Statistics

View Usage Statistics

RECENTLY ADDED

Last submissions
Repository
How to publish
Resources
FAQs

Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

Author:
Berenguer Berenguer, Juan; González García, Juan; Ribera Pascuet, Esteban; Domingo Pedrol, Pere; Santos González, Jesús; Miralles Martín, Pilar; Ribas del Blanco, María Ángeles; Asensi Álvarez, VíctorUniovi authority; Gimeno-Bayón Cobos, Juan Luis; Pérez Molina, José Antonio; Terrón Pernía, José Alberto; Santamaría Jáuregui, Juan Miguel; Pedrol Clotet, Enric
Publication date:
2008
Publisher version:
http://dx.doi.org/10.1086/592114
Citación:
Clinical Infectious Diseases, 47(8), p. 1083-1092 (2008); doi:10.1086/592114
Descripción física:
p. 1083-1092
URI:
http://hdl.handle.net/10651/11349
ISSN:
1058-4838; 1537-6591
Identificador local:

227

DOI:
10.1086/592114
Collections
  • Artículos [37549]
Files in this item
Métricas
Compartir
Exportar a Mendeley
Estadísticas de uso
Estadísticas de uso
Metadata
Show full item record
Página principal Uniovi

Biblioteca

Contacto

Facebook Universidad de OviedoTwitter Universidad de Oviedo
The content of the Repository, unless otherwise specified, is protected with a Creative Commons license: Attribution-Non Commercial-No Derivatives 4.0 Internacional
Creative Commons Image